{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:54:00Z","timestamp":1768578840066,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.7759\/cureus.101638","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:11:19Z","timestamp":1768529479000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuromyelitis Optica Spectrum Disorder Initially Presenting With Meningitis-Like Symptoms: A Case Report"],"prefix":"10.7759","author":[{"given":"Yuki","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinatsu","family":"Sakuragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp V","year":"2021","unstructured":"Papp V, Magyari M, Aktas O, et al.. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021, 96:59-77. 10.1212\/WNL.0000000000011153","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12452-8","article-title":"Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis","volume":"271","author":"Arnett S","year":"2024","unstructured":"Arnett S, Chew SH, Leitner U, et al.. Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis. J Neurol. 2024, 271:4794-812. 10.1007\/s00415-024-12452-8","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0271-0","article-title":"Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica","volume":"251","author":"Ghezzi A","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V, et al.. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol. 2004, 251:47-52. 10.1007\/s00415-004-0271-0","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-003-0098-y","article-title":"Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse","volume":"24","author":"Milano E","year":"2003","unstructured":"Milano E, Di Sapio A, Malucchi S, et al.. Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. Neurol Sci. 2003, 24:130-3. 10.1007\/s10072-003-0098-y","journal-title":"Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF, and MRI findings in Devic's neuromyelitis optica","volume":"60","author":"O'Riordan JI","year":"1996","unstructured":"O'Riordan JI, Gallagher HL, Thompson AJ, et al.. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996, 60:382-7. 10.1136\/jnnp.60.4.382","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-004-0343-z","article-title":"Cerebrospinal fluid findings in Devic's neuromyelitis optica","volume":"25","author":"Zaffaroni M","year":"2004","unstructured":"Zaffaroni M. Cerebrospinal fluid findings in Devic's neuromyelitis optica. Neurol Sci. 2004, 25:S368-70. 10.1007\/s10072-004-0343-z","journal-title":"Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-008-0002-x","article-title":"Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis","volume":"30","author":"Lepur D","year":"2009","unstructured":"Lepur D, Peterkovi\u0107 V, Kalabri\u0107-Lepur N. Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol Sci. 2009, 30:51-4. 10.1007\/s10072-008-0002-x","journal-title":"Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04871.x","article-title":"Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica","volume":"1173","author":"Cayrol R","year":"2009","unstructured":"Cayrol R, Saikali P, Vincent T. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Ann N Y Acad Sci. 2009, 1173:478-86. 10.1111\/j.1749-6632.2009.04871.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-000753","article-title":"A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia (Article in Japanese)","volume":"56","author":"Fujikura M","year":"2016","unstructured":"Fujikura M, Yokokawa K, Shizukawa H, Shimohama S. A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia (Article in Japanese). Rinsho Shinkeigaku. 2016, 56:569-72. 10.5692\/clinicalneurol.cn-000753","journal-title":"Rinsho Shinkeigaku"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938492","article-title":"Aquaporin 4-positive neuromyelitis optica spectrum disorder with meningoencephalitis-like onset: a case report","volume":"13","author":"Bu Y","year":"2022","unstructured":"Bu Y, Liu H, Qian X, Sun F, Li C, Han J. Aquaporin 4-positive neuromyelitis optica spectrum disorder with meningoencephalitis-like onset: a case report. Front Immunol. 2022, 13:938492. 10.3389\/fimmu.2022.938492","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.050","article-title":"Suspected bacterial meningoencephalomyelitis as the trigger or presentation of neuromyelitis optica spectrum disorder flare","volume":"30","author":"He M","year":"2019","unstructured":"He M, Gao D, Zhang J, Huang D, Tian Y, Yu S. Suspected bacterial meningoencephalomyelitis as the trigger or presentation of neuromyelitis optica spectrum disorder flare. Mult Scler Relat Disord. 2019, 30:38-41. 10.1016\/j.msard.2019.01.050","journal-title":"Mult Scler Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.05.013","article-title":"Suspected bacterial meningomyelitis: the first presenting clinical feature of neuromyelitis optica spectrum disorder","volume":"309","author":"Li X","year":"2017","unstructured":"Li X, Lin J, Pan S, et al.. Suspected bacterial meningomyelitis: the first presenting clinical feature of neuromyelitis optica spectrum disorder. J Neuroimmunol. 2017, 309:68-71. 10.1016\/j.jneuroim.2017.05.013","journal-title":"J Neuroimmunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001316","article-title":"A case of suspected neuromyelitis optica spectrum disorder preceded by aseptic meningitis-like symptoms (Article in Japanese)","volume":"59","author":"Odachi K","year":"2019","unstructured":"Odachi K, Iio K, Uno K, Kawada N, Tomimoto H. A case of suspected neuromyelitis optica spectrum disorder preceded by aseptic meningitis-like symptoms (Article in Japanese). Rinsho Shinkeigaku. 2019, 59:736-9. 10.5692\/clinicalneurol.cn-001316","journal-title":"Rinsho Shinkeigaku"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003278","article-title":"Clinical reasoning: bacterial meningitis causing a neuromyelitis optica flare","volume":"87","author":"Saab F","year":"2016","unstructured":"Saab F, Stutz M, Restrepo L. Clinical reasoning: bacterial meningitis causing a neuromyelitis optica flare. Neurology. 2016, 87:e215-8. 10.1212\/WNL.0000000000003278","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102013","article-title":"Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare","volume":"41","author":"Shi B","year":"2020","unstructured":"Shi B, Jiang W, He M, et al.. Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare. Mult Scler Relat Disord. 2020, 41:102013. 10.1016\/j.msard.2020.102013","journal-title":"Mult Scler Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512459785","article-title":"Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder","volume":"19","author":"Wang JY","year":"2013","unstructured":"Wang JY, Wang K, Chen XW, Wang JW, Zhang K, Xu MW, Luo BY. Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler. 2013, 19:639-43. 10.1177\/1352458512459785","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02133-8","article-title":"Meningitis as a recurrent manifestation of anti-AQP4\/anti-MOG negative neuromyelitis optica spectrum disorder: a case report","volume":"21","author":"Zhang C","year":"2021","unstructured":"Zhang C, Zhang K, Chen B, Yin J, Dong M, Qin Y, Yang X. Meningitis as a recurrent manifestation of anti-AQP4\/anti-MOG negative neuromyelitis optica spectrum disorder: a case report. BMC Neurol. 2021, 21:109. 10.1186\/s12883-021-02133-8","journal-title":"BMC Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk DM","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999, 53:1107-14. 10.1212\/wnl.53.5.1107","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282x20130020","article-title":"Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease","volume":"71","author":"Bichuetti DB","year":"2013","unstructured":"Bichuetti DB, Oliveira EM, Souza NA, Tintor\u00e9 M, Gabbai AA. Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease. Arq Neuropsiquiatr. 2013, 71:275-9. 10.1590\/0004-282x20130020","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/432186-neuromyelitis-optica-spectrum-disorder-initially-presenting-with-meningitis-like-symptoms-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:11:21Z","timestamp":1768529481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/432186-neuromyelitis-optica-spectrum-disorder-initially-presenting-with-meningitis-like-symptoms-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.101638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}